Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

Because the hedgehog signalling pathway plays a major role in many types of cancer and can nowadays be targeted by specific compounds, we aimed to investigate the role of this pathway in squamous cell carcinoma of the head and neck.

• Publication year

  2019

• Venue

  Histopathology

• Publication date

  2019-05-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/his.13860PMID 30861166PMCID 6851882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

  2019cited by this paper
• Cancer statistics, 2018

  2018cited by this paper
• Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma

  2017cited by this paper
• Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients

  2017cited by this paper
• Systemic therapy for head and neck squamous cell carcinoma: Historical perspectives and recent breakthroughs

  2017cited by this paper
• A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma.

  2016cited by this paper
• Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.

  2016cited by this paper
• Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy

  2016cited by this paper
• Immunohistochemical evaluation of hedgehog signalling in epithelial/mesenchymal interactions in squamous cell carcinoma transformation: a pilot study.

  2016cited by this paper
• Emerging from their burrow: Hedgehog pathway inhibitors for cancer

  2016cited by this paper
• American Cancer Society Head and Neck Cancer Survivorship Care Guideline

  2016cited by this paper
• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

  2016cited by this paper
• Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors

  2016cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features

  2014cited by this paper
• Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.

  2014cited by this paper
• Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer.

  2013cited by this paper
• Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

  2011cited by this paper
• Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.

  2009cited by this paper
• Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase‐9 activation

  2008cited by this paper
• Urological Survey UROLOGICAL ONCOLOGY: PROSTATE CANCER Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis

  2005cited by this paper
• Hedgehog signalling in cancer formation and maintenance

  2003cited by this paper
• IKKb Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

  year unknowncited by this paper

• Immunohistochemical expression of smoothened in periocular basal cell, squamous cell and sebaceous carcinomas

  2025cites this paper
• Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature

  2024cites this paper
• Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India.

  2024cites this paper
• Primary cilia-associated signalling in squamous cell carcinoma of head and neck region

  2024cites this paper
• Targeted therapy for head and neck cancer: signaling pathways and clinical studies

  2023cites this paper
• Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway

  2023cites this paper
• The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• New insights into RAS in head and neck cancer.

  2023cites this paper
• Differential promoter usages of PTCH1 and down regulation of HHIP are associated with HNSCC progression.

  2022cites this paper
• Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers

  2022cites this paper
• The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis

  2021cites this paper
• Running title: SHH is a novel prognostic biomarker in oral carcinoma

  2021influential citation
• Identification of new hypoxia‐regulated epithelial‐mesenchymal transition marker genes labeled by H3K4 acetylation

  2020cites this paper
• GANT61 and Lithium Chloride Inhibit the Growth of Head and Neck Cancer Cell Lines Through the Regulation of GLI3 Processing by GSK3β

  2020cites this paper
• Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

  2019cites this paper